Holocene Advisors LP Lowers Stock Position in GE HealthCare Technologies Inc. $GEHC

Holocene Advisors LP cut its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 7.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,717,921 shares of the company’s stock after selling 309,431 shares during the quarter. Holocene Advisors LP owned approximately 0.82% of GE HealthCare Technologies worth $279,216,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Dodge & Cox lifted its holdings in GE HealthCare Technologies by 42.1% during the second quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock valued at $1,745,678,000 after purchasing an additional 6,982,441 shares in the last quarter. Norges Bank purchased a new stake in shares of GE HealthCare Technologies in the second quarter worth $468,120,000. Capital Research Global Investors raised its position in shares of GE HealthCare Technologies by 25.0% during the 3rd quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock valued at $1,875,400,000 after purchasing an additional 4,998,154 shares during the period. Boston Partners purchased a new position in shares of GE HealthCare Technologies during the 3rd quarter valued at $287,627,000. Finally, Temasek Holdings Private Ltd purchased a new position in shares of GE HealthCare Technologies during the 3rd quarter valued at $99,922,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Up 0.6%

Shares of GEHC stock opened at $70.77 on Monday. The company’s fifty day simple moving average is $80.78 and its two-hundred day simple moving average is $78.54. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $89.77. The stock has a market cap of $32.25 billion, a P/E ratio of 15.52, a PEG ratio of 1.56 and a beta of 1.03. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. The firm had revenue of $5.70 billion during the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The business’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter last year, the business posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be paid a $0.035 dividend. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is presently 3.07%.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. BTIG Research increased their price target on GE HealthCare Technologies from $87.00 to $91.00 and gave the stock a “buy” rating in a research note on Wednesday, February 4th. Wells Fargo & Company upped their price objective on GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Jefferies Financial Group increased their target price on GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Thursday, December 11th. Stifel Nicolaus boosted their price target on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a “buy” rating in a report on Wednesday, February 4th. Finally, UBS Group downgraded GE HealthCare Technologies from a “neutral” rating to a “sell” rating and upped their price target for the stock from $73.00 to $77.00 in a research note on Thursday, January 15th. Seven investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $92.17.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.